The aim of this study was to establish the expression pattern of VEGF, HIF-1α, HIF-2α and CA9 in a series of pancreatic endocrine tumours and to correlate the level of expression with clinicopathological charateristics, angiogenesis and survival. This evidence concerns the gene EPAS1 and pancreatic neuroendocrine tumor.